Article Versions Notes

Schnapp A, Harel M, Cayam-Rand D, Cassuto H, Polyansky L, Aran A. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines. 2022; 10(7):1685. https://doi.org/10.3390/biomedicines10071685

Schnapp, Aviad, Moria Harel, Dalit Cayam-Rand, Hanoch Cassuto, Lola Polyansky, and Adi Aran. 2022. "A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ" Biomedicines 10, no. 7: 1685. https://doi.org/10.3390/biomedicines10071685

Schnapp, A., Harel, M., Cayam-Rand, D., Cassuto, H., Polyansky, L., & Aran, A. (2022). A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines, 10(7), 1685. https://doi.org/10.3390/biomedicines10071685